Organon & Co (OGN)

Official site

HEALTHCARE • DRUG MANUFACTURERS - GENERAL • NYSE

$13.85

+0.06 (+0.44%)

Market Cap: $3.62B

Last updated: Nov 06, 2026 at 4:15 PM ET

Earnings

Performance (10Y)

Beat Rate

65%(15/23)

Avg Surprise

+5.42%

Upcoming Estimates

Period ending Dec 31, 2026

EPS Consensus$0.57

Range$0.43 - $0.85

4 analysts

Revenue Consensus

$1.5B

Range$1.5B - $1.6B

3 analysts

Last 12 of 23 reported quarters and 1 upcoming estimate

Period	Reported	Est.	Range	Surprise	B/M	Analysts	Revisions	YoY
Dec 31, 2026Dec 26EST	-	$0.57	$0.43 - $0.85	-	-	4	-	-
Sep 30, 2026Sep 26 Reported Oct 30, 2026Reported Oct 30	$0.88	$0.95	$0.88 - $1.05	-7.37%	Miss	3	No revisions (30d)	-12.9%
Jun 30, 2026Jun 26 Reported Jul 31, 2026Reported Jul 31	$0.80	$0.85	$0.85 - $0.85	-5.88%	Miss	1	No revisions (30d)	-20.0%
Mar 31, 2026Mar 26 Reported Apr 30, 2026Reported Apr 30	$0.71	$0.85	$0.77 - $0.95	-16.47%	Miss	6	2 1 30d	-30.4%
Dec 31, 2025Dec 25 Reported Feb 12, 2026Reported Feb 12	$0.63	$0.73	$0.62 - $0.81	-13.70%	Miss	7	0 1 30d	-30.0%
Sep 30, 2025Sep 25 Reported Nov 10, 2025Reported Nov 10	$1.01	$0.93	$0.89 - $0.97	+8.60%	Beat	5	1 1 30d	+16.1%
Jun 30, 2025Jun 25 Reported Aug 5, 2025Reported Aug 5	$1.00	$0.94	$0.90 - $0.99	+6.38%	Beat	5	1 0 30d	-10.7%
Mar 31, 2025Mar 25 Reported May 1, 2025Reported May 1	$1.02	$0.89	$0.86 - $0.94	+14.61%	Beat	5	0 1 30d	-16.4%
Dec 31, 2024Dec 24 Reported Feb 13, 2025Reported Feb 13	$0.90	$0.87	$0.82 - $0.93	+3.45%	Beat	7	1 1 30d	+2.3%
Sep 30, 2024Sep 24 Reported Oct 31, 2024Reported Oct 31	$0.87	$0.90	$0.78 - $1.11	-3.33%	Miss	7	0 2 30d	+0.0%
Jun 30, 2024Jun 24 Reported Aug 6, 2024Reported Aug 6	$1.12	$1.08	$0.93 - $1.24	+3.70%	Beat	7	0 2 30d	-14.5%
Mar 31, 2024Mar 24 Reported May 2, 2024Reported May 2	$1.22	$0.93	$0.88 - $1.22	+31.18%	Beat	6	4 1 30d	+13.0%
Dec 31, 2023Dec 23 Reported Feb 15, 2024Reported Feb 15	$0.88	$0.83	$0.68 - $1.07	+6.02%	Beat	7	2 0 30d	+8.6%

Dividends

Next ex-dividend: Nov 9, 2026

Dividend Metrics

Forward Yield0.58%

Forward Annual Dividend$0.08

Payout Ratio2.49%

FrequencyQuarterly

Pay MonthsMar, Jun, Sep, Dec

Growth

3Y CAGR-62.30%

OGN dividend history and ex-dividend dates Run OGN in the free DRIP calculator

Key Metrics

Valuation
P/E Ratio	4.59	EV/EBITDA	8.38x
Price/FCF	5.39x	FCF Yield	18.56%
Profitability
Profit Margin	3.49%	Operating Margin	23.20%
ROE	20.30%	ROIC	6.25%
Financial Health
Debt/Equity	7.17x	Interest Coverage	2.16x
Current Ratio	2.02x	Quick Ratio	1.51x
Trading Statistics
Beta	1.49	Avg Volume	2.49M
52-Week High	$13.88	52-Week Low	$5.67

Technical Indicators Dashboard

Moving Averages

SMA 10$13.81

SMA 20$13.78

SMA 50$13.74

SMA 200$11.62

EMA 10$13.81

EMA 20$13.79

EMA 50$13.71

EMA 200$12.20

MACD

Line: 0.03Signal: 0.02Hist: 0.00

ADX

ADX: 33.1+DI: 20.8-DI: 12.4

Aroon & PSAR

Aroon Up92.0

Aroon Down4.0

PSAR$13.76

Bollinger Bands

Upper Band$13.86

Lower Band$13.70

%B Position111%(Upper)

Band Width0.95

RSI (14-Day)

Neutral

61.9

Momentum Oscillators

Stoch %K64.6

Stoch %D72.9

Williams %R-21.4

ROC (10d)0.7%

Momentum0.10

CCI (20d)95.2

MFI (14d)68.0

Volatility Measures

ATR (14d)$0.04(0.3%)

StdDev (20d)0.04

Hist Vol3.0%(Low)

Volume Flow

VWAP$13.83

OBV302.4M

AD Line-801.2M

CMF (20d)-0.028

Volume Metrics

Avg Vol (20d)2.5M

Vol Ratio1.6x(High)

VWMA (20d)$13.79

Pivot Points

R3$13.91

R2$13.88

R1$13.84

Pivot Point$13.81

S1$13.77

S2$13.74

S3$13.70

Advanced Oscillators

TSI19.24

Ultimate Osc49.8

KST5.32

Financial Data

Quarter	Sep 2026	Jun 2026	Mar 2026	Dec 2025	Sep 2025	Jun 2025	Mar 2025	Dec 2024	Sep 2024	Jun 2024	Mar 2024	Dec 2023
Total Revenue	$1.57B	$1.56B	$1.46B	$1.51B	$1.60B	$1.59B	$1.51B	$1.59B	$1.58B	$1.61B	$1.62B	$1.60B
Cost of Revenue	$705.00M	$711.00M	$677.00M	$766.00M	$745.00M	$720.00M	$672.00M	$696.00M	$659.00M	$668.00M	$665.00M	$683.00M
Gross Profit	$869.00M	$847.00M	$783.00M	$741.00M	$857.00M	$874.00M	$841.00M	$896.00M	$923.00M	$939.00M	$957.00M	$915.00M

Operating Expenses	$504.00M	$525.00M	$548.00M	$832.00M	$499.00M	$550.00M	$608.00M	$608.00M	$584.00M	$568.00M	$581.00M	$661.00M
R&D	$83.00M	$91.00M	$93.00M	$91.00M	$84.00M	$95.00M	$102.00M	$130.00M	$162.00M	$131.00M	$127.00M	$134.00M
SG&A	$421.00M	$434.00M	$424.00M	$433.00M	$415.00M	$453.00M	$420.00M	$470.00M	$422.00M	$437.00M	$431.00M	$469.00M
Operating Income	$365.00M	$322.00M	$235.00M	$-91,000,000	$358.00M	$324.00M	$233.00M	$288.00M	$339.00M	$371.00M	$376.00M	$254.00M

Interest Income	$0	$0	$0	$0	$0	$0	$0	$0	$0	$0	$0	$0
Interest Expense	$106.00M	$108.00M	$111.00M	$109.00M	$128.00M	$131.00M	$124.00M	$132.00M	$126.00M	$131.00M	$131.00M	$128.00M
Income Before Tax	$255.00M	$183.00M	$213.00M	$-148,000,000	$243.00M	$229.00M	$101.00M	$129.00M	$207.00M	$235.00M	$236.00M	$104.00M
Income Tax Expense	$91.00M	$75.00M	$67.00M	$57.00M	$83.00M	$84.00M	$14.00M	$20.00M	$-152,000,000	$40.00M	$35.00M	$-442,000,000

Net Income	$164.00M	$108.00M	$146.00M	$-205,000,000	$160.00M	$145.00M	$87.00M	$109.00M	$359.00M	$195.00M	$201.00M	$546.00M

EBITDA	$443.00M	$371.00M	$410.00M	$57.00M	$463.00M	$449.00M	$309.00M	$338.00M	$402.00M	$432.00M	$432.00M	$292.00M
EBIT	$361.00M	$291.00M	$324.00M	$-39,000,000	$371.00M	$360.00M	$225.00M	$261.00M	$333.00M	$366.00M	$367.00M	$232.00M

* Some calculated fields are derived from available data when not provided by source

Related GNG Research

No research available

Be the first to write about OGN

News

A cream treats eczema in adults and children 2 and older. Organon will present a new analysis across patient groups.

Organon (NYSE: OGN) announced it will present new analysis of its Phase 3 VTAMA cream data at the 2026 American College of Allergy...

Stock Titan•Nov 5, 2026 8:10 AM ET11/5/26•Neutral

Organon & Co. (OGN) Stock Price, News, Quote & History

This page provides a comprehensive overview of Organon & Co. (OGN) stock, including real-time and overnight trading prices, historical data...

Yahoo! Finance Canada•Nov 1, 2026 1:10 AM ET11/1/26•Neutral

Q3 revenue fell to $1.57B at Organon (OGN), but profit moved the other way.

Organon (OGN) reported a 2% decrease in third-quarter 2026 revenue to $1.574 billion, down from $1.602 billion a year earlier, but net income rose to $164 million from $160 million. For the first nine months of 2026...

Stock Titan•Oct 31, 2026 1:10 AM ET10/31/26•Neutral

Press Release: Organon Announces Quarterly Dividend

Organon (NYSE: OGN) has announced a quarterly dividend of $0.36 per share of common stock, payable on December 14, 2023, to shareholders of record as of November 20...

Moomoo•Oct 30, 2026 11:11 AM ET10/30/26•Bullish

Form 8K Organon & Co For: 30 October By Investing.com

This article reports that Organon & Co. filed a Form 8K on October 30, 2026. The filing is a routine disclosure document for significant events that shareholders should know about. No specific details of the 8K filing...

Investing.com South Africa•Oct 30, 2026 10:22 AM ET10/30/26•Neutral

OGN Valuation and Fair Value

P/E: 4.6x
Forward P/E: 5.1x
EV/EBITDA: 8.4x
P/FCF: 5.4x
P/B: 3.0x

See GNG's fair value

OGN Profitability: Margins, ROIC and FCF

Gross margin: 53.1%
Operating margin: 23.2%
Net margin: 3.5%
ROIC: 6.2%
ROE: 20.3%
FCF margin: 11.1%
FCF yield: 18.6%

OGN Competitors

Company	Ticker
Xenon Pharmaceuticals Inc	XENE
Stevanato Group SpA	STVN
Catalyst Pharmaceuticals Inc	CPRX
Viking Therapeutics Inc	VKTX
Tango Therapeutics Inc	TNGX
Disc Medicine Inc.	IRON
Iovance Biotherapeutics Inc	IOVA
Cidara Therapeutics Inc	CDTX

Sector: Healthcare

OGN Analyst Ratings

Consensus: Hold
Analysts: 5
Strong Buy: 0
Buy: 0
Hold: 4
Sell: 0
Strong Sell: 1

OGN Bull Case vs Bear Case

Bear case

OGN's quarterly revenue changed -1.7% year over year.
OGN has a debt-to-equity ratio of 7.2x.

OGN Earnings: Beat Rate and Next Report

Beat rate: 4 of 8 quarters (50.0%)
Average surprise: -1.3%
EPS estimate (fiscal period ending Dec 31, 2026): $0.57

OGN Dividend

Forward yield: 0.6%
Payout ratio: 2.5%
3Y DPS growth: -62.3%
Pay months: Mar, Jun, Sep, Dec

OGN dividend history

OGN Earnings Date

OGN reports Feb 10, 2027, after the close. The date is estimated.

OGN Earnings Call

The latest OGN earnings call transcript on file is labeled 2025Q4.

Read the 2025Q4 transcript

OGN ETF Holders

GNG tracks 16 ETFs that hold OGN. The largest weights:

NYLIM Merger Arbitrage ETF (MNA), 2.75% of the fund
State Street SPDR S&P Pharmaceuticals ETF (XPH), 2.02% of the fund
iShares Core S&P Small-Cap ETF (IJR), 0.21% of the fund
Schwab Fundamental U.S. Large Company Index ETF (FNDX), 0.10% of the fund
Vanguard Morningstar Small-Cap Value ETF (VBR), 0.08% of the fund

Open the ETF Stock Exposure tool for OGN

See insider activity

Frequently Asked Questions About OGN

When is OGN's next ex-dividend date?

OGN's next ex-dividend date is Nov 9, 2026, for a declared dividend of $0.02 per share (record date Nov 9, 2026, payable Dec 10, 2026).

When does OGN report earnings?

Organon & Co (OGN) is expected to report earnings on Feb 10, 2027.

What is OGN's current dividend yield?

Organon & Co (OGN) has a forward dividend yield of 0.58%.

Does OGN pay dividends?

Yes, Organon & Co pays dividends with a forward dividend yield of 0.58%.

What is OGN's P/E ratio?

Organon & Co has a price-to-earnings (P/E) ratio of 4.59.

Get full access to GNG Research

Create a free account to access portfolio tracking, advanced tools, and more.

Create Free Account Log In